Vivos Therapeutics
VVOS----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Vivos Therapeutics(VVOS) predict that the Revenue is 5.141 M (+70.46%), Beat estimate;the EBIT is -6.615 M (-68.84%), Miss estimate;the EPS is -0.52 (-15.56%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B70.46%
0.00B44.19%
+0.00B26.27%
EBITMiss expectations
-0.01B68.84%
-0.01B52.27%
-0.00B16.57%
EPSMiss expectations
-0.5215.56%
-0.45330.74%
-0.066714.82%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf